Related references
Note: Only part of the references are listed.Systematic Review and Meta-analysis of the Most Common Genetic Mutations in Esophageal Squamous Cell Carcinoma
Amirreza Naseri et al.
JOURNAL OF GASTROINTESTINAL CANCER (2022)
MicroRNAs Involved in Inflammatory Breast Cancer: Oncogene and Tumor Suppressors with Possible Targets
Zohreh Rezaei et al.
DNA AND CELL BIOLOGY (2021)
Perspectives of Esophageal Cancer Survivors on Diagnosis, Treatment, and Recovery
Annemarie E. Bennett et al.
CANCERS (2021)
MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN
Kun Guo et al.
TISSUE & CELL (2021)
ELK4-mediated lncRNA SNHG22 promotes gastric cancer progression through interacting with EZH2 and regulating miR-200c-3p/Notch1 axis
Xiaqiong Mao et al.
CELL DEATH & DISEASE (2021)
Profile of esophageal squamous cell carcinoma mutations in Brazilian patients
Fernanda Franco Munari et al.
SCIENTIFIC REPORTS (2021)
A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR
Fatemeh Fardi Golyan et al.
ADVANCES IN MEDICAL SCIENCES (2021)
Partial EMT in Squamous Cell Carcinoma: A Snapshot
Chengcheng Liao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma
Qingqing Feng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Transcriptomic and Functional Screens Reveal MicroRNAs That Modulate Prostate Cancer Metastasis
Srinivasa R. Rao et al.
FRONTIERS IN ONCOLOGY (2020)
Structural heterogeneity of the mammalian polycomb repressor complex in immune regulation
Seok-Jin Kang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
EZH2: a novel target for cancer treatment
Ran Duan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Mechanisms and Functions of MiR-200 Family in Hepatocellular Carcinoma
Yinqi Mao et al.
ONCOTARGETS AND THERAPY (2020)
EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas
Camille Lachat et al.
CANCERS (2020)
An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells
Valentina Perotti et al.
ONCOGENE (2019)
Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer
Zamira Vanessa Diaz-Riascos et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
Occurrence of the potent mutagens 2-nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles
Aldenor G. Santos et al.
SCIENTIFIC REPORTS (2019)
Epigenetic Regulation of EMT (Epithelial to Mesenchymal Transition) and Tumor Aggressiveness: A View on Paradoxical Roles of KDM6B and EZH2
Camille Lachat et al.
EPIGENOMES (2019)
A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization
Ashley Di Meo et al.
ONCOTARGET (2018)
EMT in Metastasis: Finding the Right Balance
Hin Ching Lo et al.
DEVELOPMENTAL CELL (2018)
Epidemiology of Esophageal Squamous Cell Carcinoma
Christian C. Abnet et al.
GASTROENTEROLOGY (2018)
The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter
Lu Gan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Tumor suppressive miR-6775-3p inhibits ESCC progression through forming a positive feedback loop with p53 via MAGE-A family proteins
Lingjiao Meng et al.
CELL DEATH & DISEASE (2018)
Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential
Lu Gan et al.
BIOMARKER RESEARCH (2018)
EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
Ke-Sin Yan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita et al.
SCIENTIFIC REPORTS (2017)
Targeting EZH2 in cancer therapy
Makoto Yamagishi et al.
CURRENT OPINION IN ONCOLOGY (2017)
Emerging roles for Polycomb proteins in cancer
Diego Pasini et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2016)
Over expression of miR-200c suppresses invasion and restores methotrexate sensitivity in lung cancer A549 cells
Wulin Shan et al.
GENE (2016)
The roles of Polycomb group proteins in hematopoietic stem cells and hematological malignancies
Emi Takamatsu-Ichihara et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells
Horacio Cardenas et al.
ONCOTARGET (2016)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients
Hai Feng et al.
JOURNAL OF HEPATOLOGY (2015)
Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications
Wei Wang et al.
MEDICINAL RESEARCH REVIEWS (2015)
Regulation of gene transcription by Polycomb proteins
Sergi Aranda et al.
SCIENCE ADVANCES (2015)
Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a driving force for prostate cancer development
Tao Tao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
Regulation of microRNAs in cancer metastasis
Juliette M. C. Bouyssou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Mechanical Feedback through E-Cadherin Promotes Direction Sensing during Collective Cell Migration
Danfeng Cai et al.
CELL (2014)
Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma
Shunji Tamagawa et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Circulating miR-200c Levels Significantly Predict Response to Chemotherapy and Prognosis of Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Cancer
Koji Tanaka et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Hui Ling et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Neoadjuvant Chemotherapy for Resectable Esophageal Carcinoma: A Meta-analysis of Randomized Clinical Trials
Xiao-Hua Xu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
Manuel Valladares-Ayerbes et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Epidemiologic differences in esophageal cancer between Asian and Western populations
Han-Ze Zhang et al.
CHINESE JOURNAL OF CANCER (2012)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA-cancer connection: The beginning of a new tale
George Adrian Calin et al.
CANCER RESEARCH (2006)
Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 french endoscopy centers
J. Dubuc et al.
ENDOSCOPY (2006)
The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3
R Cao et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Share Paper
